Gene Bio Systems
SKU:CE211
Regular price
€193,95 EUR
Regular price
Sale price
€193,95 EUR
Unit price
/
per
Sale
Sold out
Couldn't load pickup availability
Features:
|
• 5 minutes fast ligation of Pfu-amplified PCR products.
• Ampicillin resistance.
• T7 promoter primer and T7 terminator primer for sequencing.
• Bacteriophage T7lac promoter for high level expression.
• C-terminal 6×His tag for easy purification.
• Trans1-T1 Phage Resistant Chemically Competent Cell, high transformation efficiency (>109 cfu/μg pUC19 DNA) and fast growing.
• E2 Expression Plasmid included as negative control.
|
|
Storage
|
Chemically Competent Cell at -70°C for six months; others at -20°C for nine months
|
|
Kit Content
|
|
Component
|
CE211-01 (10 rxns)
|
|
pEASY®-Blunt E2 Expression Vector (15 ng/μl)
|
10 µl
|
|
E2 Expression Plasmid (Negative Control) (15 ng/μl)
|
10 µl
|
|
EControl Template (5 ng/μl)
|
10 µl
|
|
EControl Forward Primer (10 μM)
|
10 µl
|
|
EControl Reverse Primer (10 μM)
|
10 µl
|
|
T7 Promoter Primer (10 μM)
|
50 µl
|
|
T7 Terminator Primer (10 μM)
|
50 µl
|
|
Trans1-T1 Phage Resistant Chemically Competent Cell
|
5×100 μl
|
|
Paper citing this product:
| Literature |
Journal |
IF |
Author |
Date |
Link |
| A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression. |
anticancer research |
1.9 |
Xiaomei Yang Shan Cheng, Department of Biochemist |
2017 Jan |
The original link |
Share
View full details